L.E.A.P.S. Technology Stimulates Maturation Of Human Blood Cells Into Dendritic Cells Suggesting Potential For Treatment Of Infectious

CEL-SCI Corporation (NYSE Amex: CVM) announced the presentation of data at the 11th annual National Foundation of Infectious Diseases Conference in Baltimore which demonstrates how vaccines utilizing its L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine technology can induce protection against infectious disease, induce immunity against HIV, and promote immunotherapy for rheumatoid arthritis. The L.E.A.P.S.

More: continued here

Filed under: Conferences on May 3rd, 2009